Table 2.

Adverse Events by Treatment Arm

Adverse events	No. of patients that refereed adverse events during the study (%)
	Cannabidiol (n=49)	Placebo (n=42)	Chi-square test p
Somnolence	38 (77.6)	33 (78.6)	0.933
Fatigue	38 (77.6)	33 (78.6)	0.933
Decreased appetite	38 (77.6)	32 (76.2)	0.860
Lethargy	25 (51.0)	15 (35.7)	0.142
Weight loss	24 (49.0)	22 (52.4)	0.761
Nausea	23 (46.9)	16 (38.1)	0.409
Diarrhea	21 (42.9)	20 (47.6)	0.392
Increased appetite	17 (34.7)	10 (23.8)	0.255
Fever	11 (22.5)	15 (45.7)	0.167
Weight gain	10 (20.4)	8 (19.1)	0.865
Vomiting	6 (12.3)	4 (9.5)	0.675
Headache	4 (8.2)	3 (7.1)	0.852
Abdominal pain	4 (8.2)	2 (4.8)	0.512
Rash	3 (6.2)	0 (0.0)	0.103
Bitter mouth	3 (6.2)	4 (9.5)	0.547